Safety and outcomes of mechanical thrombectomy for acute stroke related to infective endocarditis: A case-control study.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 10 5 2020
medline: 26 10 2021
entrez: 9 5 2020
Statut: ppublish

Résumé

Successful reperfusion can be achieved in more than two-thirds of patients with usual large-vessel occlusion stroke causes treated with mechanical thrombectomy. However, the safety and outcomes after mechanical thrombectomy in the setting of large-vessel occlusion related to infective endocarditis is not known. In this study, we investigated the impact of mechanical thrombectomy in infective endocarditis patients on angiographic and clinical outcomes. This was a multicenter study from five comprehensive stroke centers. We compared the outcomes of mechanical thrombectomy treated stroke patients due to infective endocarditis with patients presenting atrial fibrillation. Clinical outcomes included 90-day modified Rankin Scale, symptomatic intracerebral hemorrhage, and mortality. Between June 2013 and March 2019, 28 patients presenting large-vessel occlusion stroke due to IE were included. These cases were matched with 84 large-vessel occlusion stroke related to atrial fibrillation. Successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b/3) was obtained in 85.7%. Symptomatic intracranial hemorrhage, favorable outcome and mortality rates were respectively 8.0%, 25.9%, and 25.9%. In the case-control analysis, we demonstrated no difference in terms of successful reperfusion, procedural complication, symptomatic intracranial hemorrhage, and mortality rates. Three-month favorable outcome was less often achieved in the infective endocarditis group. Mechanical thrombectomy of infective endocarditis patients presents similar safety and angiographic results compared to patients suffering from atrial fibrillation.

Sections du résumé

BACKGROUND AND PURPOSE
Successful reperfusion can be achieved in more than two-thirds of patients with usual large-vessel occlusion stroke causes treated with mechanical thrombectomy. However, the safety and outcomes after mechanical thrombectomy in the setting of large-vessel occlusion related to infective endocarditis is not known. In this study, we investigated the impact of mechanical thrombectomy in infective endocarditis patients on angiographic and clinical outcomes.
METHODS
This was a multicenter study from five comprehensive stroke centers. We compared the outcomes of mechanical thrombectomy treated stroke patients due to infective endocarditis with patients presenting atrial fibrillation. Clinical outcomes included 90-day modified Rankin Scale, symptomatic intracerebral hemorrhage, and mortality.
RESULTS
Between June 2013 and March 2019, 28 patients presenting large-vessel occlusion stroke due to IE were included. These cases were matched with 84 large-vessel occlusion stroke related to atrial fibrillation. Successful reperfusion (modified Thrombolysis in Cerebral Infarction 2b/3) was obtained in 85.7%. Symptomatic intracranial hemorrhage, favorable outcome and mortality rates were respectively 8.0%, 25.9%, and 25.9%. In the case-control analysis, we demonstrated no difference in terms of successful reperfusion, procedural complication, symptomatic intracranial hemorrhage, and mortality rates. Three-month favorable outcome was less often achieved in the infective endocarditis group.
CONCLUSIONS
Mechanical thrombectomy of infective endocarditis patients presents similar safety and angiographic results compared to patients suffering from atrial fibrillation.

Identifiants

pubmed: 32380901
doi: 10.1177/1747493020925360
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

585-592

Commentaires et corrections

Type : ErratumIn

Auteurs

Gaultier Marnat (G)

Department of Diagnostic and Interventional Neuroradiology, University Hospital of Bordeaux, Bordeaux, France.

Igor Sibon (I)

Department of Neurology, Stroke Center, University Hospital of Bordeaux, Bordeaux, France.

Benjamin Gory (B)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France.

Sébastien Richard (S)

Department of Neurology, Stroke Unit, University Hospital of Nancy, Nancy, France.

Stéphane Olindo (S)

Department of Neurology, Stroke Center, University Hospital of Bordeaux, Bordeaux, France.

Arturo Consoli (A)

Department of Diagnostic and Interventional Neuroradiology, Foch Hospital, Versailles Saint-Quentin en Yvelines University, Suresnes, France.

Romain Bourcier (R)

Department of Neuroradiology, University Hospital of Nantes, Nantes, France.

Maeva Kyheng (M)

Université Lille, CHU Lille, EA 2694-Santé Publique: Épidémiologie et Qualité des Soins, Lille, France.

Julien Labreuche (J)

Université Lille, CHU Lille, EA 2694-Santé Publique: Épidémiologie et Qualité des Soins, Lille, France.

Cyril Darganzali (C)

Department of Diagnostic and Interventional Neuroradiology, CHRU Gui de Chauliac, Montpellier, France.

Adrien Ter Schiphorst (A)

Department of Neurology, CHRU Gui de Chauliac, Montpellier, France.

Florent Gariel (F)

Department of Diagnostic and Interventional Neuroradiology, University Hospital of Bordeaux, Bordeaux, France.

Raphaël Blanc (R)

Department of Interventional Neuroradiology, Rothschild Foundation, Paris, France.

Bertrand Lapergue (B)

Department of Neurology, Foch Hospital, Versailles Saint-Quentin en Yvelines University, Suresnes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH